Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lactospey is a line of probiotic products developed by SPEY, designed to support and restore normal intestinal microflora. The product line includes various formulations such as Lactospey capsules, Lactospey Enteric Ecol, Lactospey Kids, Lactospey Baby, and Lactospey Drops. The standard Lactospey capsules contain a mixture of live lyophilized lactic acid bacteria, including Lactobacillus acidophilus, Lactobacillus rhamnosus, Bifidobacterium bifidum, Bifidobacterium longum, and Bifidobacterium infantis, along with fructooligosaccharides (FOS) as a prebiotic. Other formulations, such as Lactospey Enteric Ecol, incorporate Saccharomyces boulardii alongside probiotic strains and inulin. Lactospey is indicated for the prevention and treatment of diarrhea (including antibiotic-associated diarrhea), acute or chronic constipation, meteorism, and other digestive disturbances.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lactospey.